Holen Sie sich die Stockscreener-App
12.69
1.40%
-0.18
Carlsmed Inc Aktie (CARL) Neueste Nachrichten
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - Ortho Spine News
Carlsmed’s personalized implants reduce spine surgery reoperations By Investing.com - Investing.com Nigeria
What is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research
Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal
Critical Comparison: Longevity Health (NASDAQ:XAGE) vs. Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Inside the J.P. Morgan healthcare event Carlsmed is joining in 2026 - Stock Titan
BTIG Reiterates Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise By Investing.com - Investing.com South Africa
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com Nigeria
CARLSMED, INC. (CARL) Competitors - Meyka
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News
Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria
Carlsmed Launches Aprevo Platform for Cervical Fusion Surgeries - marketscreener.com
Carlsmed launches personalized cervical fusion implant system - Investing.com
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - GlobeNewswire Inc.
Comparing Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. Stock (I82)Quote Deutsche Boerse AG - MarketScreener
Carlsmed, Inc.: Dividend historical data and projections - MarketScreener
Carlsmed, Inc.: Financial Data Forecasts Estimates and Expectations | I82 | US14280C1053 - MarketScreener
Carlsmed, Inc.: Revenue and Earnings Analysts Forecasts Revisions | I82 | US14280C1053 - MarketScreener
Carlsmed: Back To Where We Started - Seeking Alpha
Discontinued operations of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed, Inc. Cash Flow – FWB:I82 - TradingView
Basic earnings per share (basic EPS) of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed Reports Strong Q3 Growth and Raises Guidance - MSN
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen - MarketBeat
Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) Critical Contrast - Defense World
Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat
BTIG Research Increases Carlsmed (NASDAQ:CARL) Price Target to $24.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Carlsmed, Inc. (CARL), Brookdale Senior Living (BKD) and Eton Pharmaceuticals (ETON) - The Globe and Mail
Carlsmed (NASDAQ:CARL) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
BTIG Maintains Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock price target raised to $24 by BTIG on strong Q3 results - Investing.com South Africa
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth By Investing.com - Investing.com Nigeria
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth - Investing.com
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - Ortho Spine News
Carlsmed Secures $60 Million Credit Facility Amendment - MSN
Carlsmed, Inc. (CARL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Carlsmed, Inc. (NASDAQ:CARL) Sees Significant Decrease in Short Interest - MarketBeat
6.07%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):